Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Lovrich SD, Jobe DA, Schell RF, Callister SM.

Clin Diagn Lab Immunol. 2005 Jun;12(6):746-51. Erratum in: Clin Diagn Lab Immunol. 2005 Sep;12(9):1139.

2.

Histopathological studies of experimental lyme disease in the dog.

Summers BA, Straubinger AF, Jacobson RH, Chang YF, Appel MJ, Straubinger RK.

J Comp Pathol. 2005 Jul;133(1):1-13.

PMID:
15904927
3.

C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.

Jobe DA, Lovrich SD, Schell RF, Callister SM.

Clin Diagn Lab Immunol. 2003 Jul;10(4):573-8.

4.

Ability of the borreliacidal antibody test to confirm lyme disease in clinical practice.

Callister SM, Jobe DA, Agger WA, Schell RF, Kowalski TJ, Lovrich SD, Marks JA.

Clin Diagn Lab Immunol. 2002 Jul;9(4):908-12.

5.

Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.

Jackson CA, Lovrich SD, Agger WA, Callister SM.

J Clin Microbiol. 2002 Jun;40(6):2070-3.

6.

Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.

Kraiczy P, Hunfeld KP, Peters S, W├╝rzner R, Ackert G, Wilske B, Brade V.

J Med Microbiol. 2000 Oct;49(10):917-28.

PMID:
11023189
7.

Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected ixodes scapularis ticks.

Callister SM, Jobe DA, Schell RF, Lovrich SD, Onheiber KL, Korshus JB.

J Clin Microbiol. 2000 Oct;38(10):3670-4.

8.

Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study.

Straubinger RK, Straubinger AF, Summers BA, Jacobson RH.

J Infect Dis. 2000 Mar;181(3):1069-81.

PMID:
10720533
9.

Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.

Wieneke CA, Lovrich SD, Callister SM, Jobe DA, Marks JA, Schell RF.

J Clin Microbiol. 2000 Jan;38(1):313-7.

10.

Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.

Rousselle JC, Callister SM, Schell RF, Lovrich SD, Jobe DA, Marks JA, Wieneke CA.

J Infect Dis. 1998 Sep;178(3):733-41.

PMID:
9728542
12.

Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?

Callister SM, Jobe DA, Schell RF, Pavia CS, Lovrich SD.

Clin Diagn Lab Immunol. 1996 Jul;3(4):399-402.

13.

Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease.

Callister SM, Schell RF, Lim LC, Jobe DA, Case KL, Bryant GL, Molling PE.

Arch Intern Med. 1994 Jul 25;154(14):1625-32.

PMID:
8031211
14.

Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1. No abstract available.

15.
16.

Lyme disease.

Steere AC.

N Engl J Med. 1989 Aug 31;321(9):586-96. Review.

PMID:
2668764
17.

Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.

Callister SM, Case KL, Agger WA, Schell RF, Johnson RC, Ellingson JL.

J Clin Microbiol. 1990 Feb;28(2):363-5.

Supplemental Content

Support Center